The Nelson Report

With new President Amanda Swoverland and CFO Francis Mitchell, Hatch Bank signals a major push to dominate the rapidly growing embedded finance market.

Japanese entertainment firm TryHard Holdings saw its stock surge on a $10M buyback, only to plummet after a conflicting capital deal sparked dilution fears.

Medical device firm CVRx is under investigation after its stock nosedived. Did management mislead investors about its salesforce stability?

A new firmware update from Xsens brings sub-5cm heave accuracy to compact IMUs, challenging larger systems and boosting marine precision and safety.

California's Golden 1 Credit Union isn't just growing; it's winning top national awards for both business and culture. What's their secret?

Serenity Mental Health Centers expands its advanced, non-medication depression treatment in Nocatee, addressing a critical need in the growing community.

As the SF Zoo faces a financial crisis, a poll reveals overwhelming public support for a bold plan to replace it with a $350M conservation-focused EcoPark.

Tech consultancy Hylaine hires veteran exec Doug Hautop as President to lead an aggressive plan to scale, targeting Fortune 1000 enterprise clients.

Denver approves a $70M public investment for a new NWSL stadium, aiming to transform a vacant industrial site and cement its place in women's sports.

Maria Montenegro, an AI and M&A expert, takes the helm of the CP & ESG unit, signaling a major push into tech-driven corporate compliance and performance.

At CES 2026, Jinxin Technology unveiled NAMI INSIGHT One, AI-powered learning glasses aiming to revolutionize education. But can it overcome the hurdles?

Former mayoral candidate Luc Rabouin takes the helm at the $500M Foundation of Greater Montréal, bringing his urban development expertise to shape its future.

With a 70-year legacy, Godrej targets the Middle East's booming market at Intersec 2026, showcasing smart, certified, and sustainable security solutions.

Savara's potential new therapy for autoimmune PAP, MOLBREEVI, gets a powerful partner in PANTHERx Rare, promising a new era of comprehensive patient care.

With key studies now complete, Biofrontera's light-based therapy Ameluz could soon offer a new weapon against widespread actinic keratosis and stubborn acne.

Rani Therapeutics starts Phase 1 trials for an oral obesity drug, challenging the injectable market with a novel delivery system and a dual-action compound.

With its CEO stepping down, Lifeist Wellness tasks its CFO with a dual role, signaling a push for stability as it navigates a tough market.

With its $20M IPO, Buda Juice plans a national expansion. Its goal: make its cold-crafted, clean-label juices the new standard for fresh beverages.

Defense tech startup Vatn Systems acquires Crewless Marine, a strategic move to vertically integrate key sensor technology and accelerate its rise in naval warfare.

Cynomi hires ThreatLocker's former CRO Shane Deegan, signaling a major push to help MSPs turn cybersecurity from a cost center into a profit engine.